Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exarta Therapeutics is a private, pre-clinical biotechnology company based in New York City. Publicly available information indicates the company is focused on oncology and is developing small-molecule therapeutics. The company appears to be an early-stage startup with limited disclosed pipeline detail, and available databases describe it broadly as a biological or biotech startup rather than a later-stage clinical company. Exarta has been listed in the Viva BioInnovator portfolio and has raised at least one venture financing round. Based on currently available public sources, Exarta remains an active private company with a very limited public footprint and no clearly disclosed named clinical assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Exarta Therapeutics.